Monday, August 31, 2026

Palantir Stock Bullish By 22% In The Last 10 Sessions

ViaNews Editorial Team

February 16, 2023

Palantir Stock Bullish By 22% In The Last 10 Sessions

(VIANEWS) - Shares of Palantir (NYSE: PLTR) jumped by a staggering 22.01% in 10 sessions from $7.94 to $9.69 at 16:09 EST on Thursday, after five sequential sessions in a row of gains. NYSE is dropping 0.22% to $15,981.58, after two successive sessions in a row of losses.

Palantir's last close was $10.11, 64.38% under its 52-week high of $28.38.

About Palantir

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community in the United States to assist in counterterrorism investigations and operations. The company provides palantir gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers palantir foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. In addition, it provides apollo, a software that enables customers to deploy their own software virtually in any environment. Palantir Technologies Inc. was incorporated in 2003 and is based in Denver, Colorado.

Earnings Per Share

As for profitability, Palantir has a trailing twelve months EPS of $-0.28.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -23.89%.

Volume

Today's last reported volume for Palantir is 85834263 which is 115.33% above its average volume of 37764700.

Yearly Top and Bottom Value

Palantir's stock is valued at $9.69 at 16:09 EST, way below its 52-week high of $28.38 and way above its 52-week low of $6.44.

Volatility

Palantir's last week, last month's, and last quarter's current intraday variation average was a negative 2.84%, a positive 0.44%, and a positive 2.99%.

Palantir's highest amplitude of average volatility was 3.22% (last week), 3.65% (last month), and 2.99% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 1.65B for the twelve trailing months.

Previous days news about Palantir (PLTR)

  • Palantir stock earnings: PLTR shoots up 23% on profitability, but citi warns on revenue. According to FXStreet on Tuesday, 14 February, "On the adjusted EPS front Palantir also managed a one-penny win with $0.04 per share. ", "Karp did not specify the GAAP figure but said Palantir would achieve between $481 and $531 million in adjusted income from operations for 2023."
  • Stocks making the biggest moves midday: palantir, NVIDIA, avis budget and more. According to CNBC on Tuesday, 14 February, "The action comes a day after Palantir reported it made a profit in the fourth quarter, its first quarter of positive GAAP income, at $31 million. "

More news about Palantir (PLTR).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com